CLC bio joins Microsoft in the BioIT Alliance
Aarhus, Denmark — January 25, 2007 — CLC bio today announced that it has joined the BioIT Alliance, a cross-industry group which unites the pharmaceutical, biotech, hardware and software industries, to explore new ways to share complex biomedical data and collaborate among multi-disciplinary teams to speed up the pace of discovery in the life sciences.
CLC bio CEO Thomas Knudsen is excited about the collaboration: “It is an honour for our company to join a network of such highly estimated companies as Microsoft, Hewlett-Packard, Sun Microsystems and others. We think this agreement will prove beneficial for all involved parties, and we’re looking forward to working together within this scientific community, developing innovative solutions and solving current issues in the post-genomic age.”
Microsoft Platform Strategy Advisor Don Rule adds: “We are thrilled to welcome CLC bio to the BioIT Alliance. They bring deep experience in bioinformations software, hardware and consulting solutions to our rapidly expanding community.”
About the BioIT Alliance
Formed in 2006, the BioIT Alliance is a cross-industry group working together to improve biomedical information technology on the Microsoft platform. Founding members include Affymetrix, Inc., Accelrys Software Inc., Amylin Pharmaceuticals, Inc., Applied Biosystems, The BioTeam Inc., Digipede Technologies LLC, Discovery Biosciences Corporation., Geospiza Inc., Hewlett-Packard Development Company, InterKnowlogy, Microsoft Corporation, Sun Microsystems Inc., VizX Labs LLC and other key companies in the pharmaceutical, biotech, hardware and software industries. Additional information about the BioIT Alliance can be found on the BioIT Alliance Web site at http://www.bioitalliance.org
About CLC bio
CLC bio is the world’s leading full-service bioinformatics solution provider, solely focusing on the development of bioinformatics: software, hardware, data analysis, and custom-designed bioinformatics algorithms.
CLC bio’s mission is to be among the most innovative bioinformatics companies in the 21st century. This is realized through:
- Development of bioinformatics software and hardware based on the latest scientific findings
- User-friendly, integrated and intuitive software solutions
- Continuous focus on customer needs and superior customer service
- Frequent product updates including the latest IT technologies and bioinformatics algorithms
- A flexible IT architecture, enabling customers to buy or develop individualized solutions at a reasonable price.
